Benzinga | Jul 31, 2020 12:55PM EDT

Piper Sandler Initiates Coverage On Albireo Pharma with Overweight Rating, Announces Price Target of $45

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Albireo Pharma (NASDAQ:ALBO) with a Overweight rating and announces Price Target of $45.